Pienta KJ - Search Results

1

The role of an 80 kDa fragment of E-cadherin in the metastatic progression of prostate cancer.

Kuefer R, Hofer MD, Gschwend JE, Pienta KJ, Sanda MG, Chinnaiyan AM, Rubin MA, Day ML. Kuefer R, et al. Among authors: pienta kj. Clin Cancer Res. 2003 Dec 15;9(17):6447-52. Clin Cancer Res. 2003. PMID: 14695147

2

Identification of nuclear matrix proteins in the cancer and normal rat prostate.

Getzenberg RH, Pienta KJ, Huang EY, Coffey DS. Getzenberg RH, et al. Among authors: pienta kj. Cancer Res. 1991 Dec 15;51(24):6514-20. Cancer Res. 1991. PMID: 1742724

3

Review of the role of androgenic hormones in the epidemiology of benign prostatic hyperplasia and prostate cancer.

Montie JE, Pienta KJ. Montie JE, et al. Among authors: pienta kj. Urology. 1994 Jun;43(6):892-9. doi: 10.1016/0090-4295(94)90163-5. Urology. 1994. PMID: 7515207 Review.

4

Role of the nuclear matrix in breast cancer.

Replogle TS, Pienta KJ. Replogle TS, et al. Among authors: pienta kj. Cancer Treat Res. 1996;83:127-40. doi: 10.1007/978-1-4613-1259-8_7. Cancer Treat Res. 1996. PMID: 8826645 Review. No abstract available.

5

The effect of castanospermine on the metastatic properties of prostate cancer cells.

Yee CS, Schwab ED, Lehr JE, Quigley M, Pienta KJ. Yee CS, et al. Among authors: pienta kj. Anticancer Res. 1997 Sep-Oct;17(5A):3659-63. Anticancer Res. 1997. PMID: 9413219

6

Change in serum prostate-specific antigen as a marker of response to cytotoxic therapy for hormone-refractory prostate cancer.

Smith DC, Dunn RL, Strawderman MS, Pienta KJ. Smith DC, et al. Among authors: pienta kj. J Clin Oncol. 1998 May;16(5):1835-43. doi: 10.1200/JCO.1998.16.5.1835. J Clin Oncol. 1998. PMID: 9586898 Clinical Trial.

7

The effect of amiloride on the metastatic properties of prostate cancer in the Dunning rat model.

Pilat MJ, Lehr JE, Quigley MM, Pienta KJ. Pilat MJ, et al. Among authors: pienta kj. Oncol Rep. 1998 Jul-Aug;5(4):889-92. doi: 10.3892/or.5.4.889. Oncol Rep. 1998. PMID: 9625839

8

Longitudinal cohort analysis of lethal prostate cancer progression in transgenic mice.

Hsu CX, Ross BD, Chrisp CE, Derrow SZ, Charles LG, Pienta KJ, Greenberg NM, Zeng Z, Sanda MG. Hsu CX, et al. Among authors: pienta kj. J Urol. 1998 Oct;160(4):1500-5. J Urol. 1998. PMID: 9751403

9

Paclitaxel-associated multimininucleation is permitted by the inhibition of caspase activation: a potential early step in drug resistance.

Panvichian R, Orth K, Day ML, Day KC, Pilat MJ, Pienta KJ. Panvichian R, et al. Among authors: pienta kj. Cancer Res. 1998 Oct 15;58(20):4667-72. Cancer Res. 1998. PMID: 9788620

10

Recombinant vaccinia-PSA (PROSTVAC) can induce a prostate-specific immune response in androgen-modulated human prostate cancer.

Sanda MG, Smith DC, Charles LG, Hwang C, Pienta KJ, Schlom J, Milenic D, Panicali D, Montie JE. Sanda MG, et al. Among authors: pienta kj. Urology. 1999 Feb;53(2):260-6. doi: 10.1016/s0090-4295(98)00539-1. Urology. 1999. PMID: 9933036

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

654 results

Search Page

Filters